Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025CancersOpen Access

Expanding Immunotherapy Beyond CAR T Cells: Engineering Diverse Immune Cells to Target Solid Tumors

View Full Paper
Ask AI
Bookmark
Share

Authors

TATereza AndreouCNConstantina NeophytouFMFotios Mpekris

Discussion

Loading...

Member takes

Overview

Reviewing diverse immune cell strategies targeting solid tumors, highlighting safety in CAR therapy efforts.

Key Points

  • Expanding the applicability of immunotherapy shows potential for improved treatment of solid tumors.
  • CAR technology for various immune cells like NK and γδ T cells has unique advantages in therapy.
  • Recent advances in artificial intelligence and pharmacological strategies enhance CAR design and production.
  • This review highlights safety considerations across different CAR therapy approaches for optimum clinical use.

Cite This Study

Andreou et al. (2025) studied this question.

synapsesocial.com/papers/68c23c66b210217d64788f41https://doi.org/10.3390/cancers17172917
View Full Paper
Ask AI
Bookmark
Share